• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Pharmacokinetics and Pharmacodynamics
Pharmacokinetics and Pharmacodynamics

... unpleasant, or even harmful effects. Side effects is to be the undesired effects unrelated to therapeutic aim and occurring at doses intended for therapeutic effect. ①It is often slight, recoverable functional alteration of the body. ②Some of side effects may make a quick recovery without withdrawal ...
University of Minnesota Medical Technology Evaluation and Market
University of Minnesota Medical Technology Evaluation and Market

... • The company must continue to submit periodic reports to FDA, including any cases of adverse reactions and appropriate quality-control records • For some medicines, FDA requires additional studies (Phase IV) to evaluate long-term effects ...
Individual Warm-up
Individual Warm-up

... cup of coffee to get going in the morning, but now you need two or three, then you have become more tolerant to the effects of caffeine. ...
Drug Metabolism
Drug Metabolism

... of Drug Information. (n.d.). Retrieved November 18, 2014, from http://epharmacology.hubpages.com/hub/Pharmacological-EffectsProdrugs-Definition-Examples-and-Sources-of-Drug-Information ...
9-12-04 Intro Terminol
9-12-04 Intro Terminol

... • All drugs will act as poisons if taken in excess • Therapeutic effect is distinguished from toxic effect by dose • Factors such as route of administration, absorption, and drug metabolism will influence amount of drug reaching site of action ...
Slide 1
Slide 1

... Food, acidity, osmolarity (滲透壓) Small intestine – main absorption site large surface care carrier systems transit time ...
Chapter 7 - Westford Academy Forensics
Chapter 7 - Westford Academy Forensics

... Drugs and Crime  A drug is a natural or synthetic substance designed to affect the subject psychologically or physiologically.  “Controlled substances” are drugs that are restricted by law  Controlled Substances Act is a law that was enacted in 1970; it lists illegal drugs, their category and th ...
factors modifying drug action
factors modifying drug action

... • Intravenous glucocorticoid acts slowly, but is specially valuable for prolonged reactions and in asthmatics. • Glucocorticoids are the only drug effective in type II, type III and type IV reactions. ...
Pharmacokinetics_200..
Pharmacokinetics_200..

... slowly into the circulation, while some of it being stored in the muscle • Antibiotics usually given this way • often used as depot preparations (slow diffusion from lipid medium – e.g. haloperidol decanoate) ...
“Off-Label” and Investigational Use of Approved Drugs and
“Off-Label” and Investigational Use of Approved Drugs and

... biologic is utilized outside of its approved labeling. IRB oversight is only required when the drug or biologic is being used in a clinical investigation. The FDA has defined “clinical investigation” to be synonymous with “research.” ...
Name of the institution
Name of the institution

... their quantities and manufacturing methodologies and hence need considerable intellectual inputs from the formulators to arrive at the best possible formulation which could be accepted by the drug authorities. Further, the formulations should comply with standards and safety specifications of the re ...
New antimicrobial drugs
New antimicrobial drugs

... that in some way target and neutralise these factors may turn a pathogenic bacterium into a relatively harmless one, vulnerable to the host’s own immune defences. Another and even more ingenious use of novel target selection is applicable to microbes that rely for sustenance or viability on factors ...
Consumer Updates > How to Dispose of Unused Medicines
Consumer Updates > How to Dispose of Unused Medicines

... and in some community drinking water supplies. “The main way drug residues enter water systems is by people taking medicines and then naturally passing them through their bodies,” says Raanan Bloom, Ph.D., an environmental assessment expert at FDA. “Many drugs are not completely absorbed or metaboli ...
Biopharmaceutics Clasification System (BCS)
Biopharmaceutics Clasification System (BCS)

... in < 250 ml water over a pH range of 1 to 7.5. A drug substance is considered HIGHLY PERMEABLE when the extent of absorption in humans is determined to be > 90% of an administered dose, based on mass-balance or in comparison to an intravenous reference dose. A drug product is considered to be RAPIDL ...
Psyc 303_2012_L Notes_Substance Use Disorders
Psyc 303_2012_L Notes_Substance Use Disorders

... -Alcohol abuse is higher among whites -Alcohol dependence is higher in whites, Native Americans, and Hispanics than Asians “Illicit” Drugs…Marijuana  Derived from Cannabis sativa  Tetrahydrocannibal (THC active ingredient in marijuana)  Leaves can be used in food, drink, or smoked -When smoked, e ...
Sedatives, Hypnotics & Anxiolytics
Sedatives, Hypnotics & Anxiolytics

... bilirubin, induce glucuronyl transferase for glucuronide conjugation • the drugs are effective in premature infants for increased bilirubin formation or any hemolytic disease or if mothers are given sulfonamides in last trimester • even in physiological jaundice that is not resolving ...
GENERAL FARMACOLOGY
GENERAL FARMACOLOGY

... (tachyphylaxis to ephedrine) ...
Fraud Control Issues After The Start of Medicare Part D
Fraud Control Issues After The Start of Medicare Part D

... Will they provide the needed drugs if they are at risk How will they treat patients with significant drug management and cost issues? How will they push costs to other payors (Part B, DVA, self-pay) How will they move people past the hole in the donut? ...
Drug dosing in HD-Almadinah-2014
Drug dosing in HD-Almadinah-2014

... between blood and dialysate (Note: hemodiafiltration with large ultrafiltration [UF] will minimize the gradient and lower drug removal) • Convection–removal of solute by UF • Important for removal of middle and large-MW drugs (> 1,000 Da) ...
Part 9: Drugs Affecting the GIT. DRUGS USED TO TREAT
Part 9: Drugs Affecting the GIT. DRUGS USED TO TREAT

...  Patients with HF or hypertension should not use antacids with high sodium content and use with caution with other medications because of the many drug interactions  Most medications should be given 1 to 2 hours after giving an antacid  Antacids may cause premature dissolving of enteric-coated me ...
Name: Date: ______ 1. All of the following are
Name: Date: ______ 1. All of the following are

... Employment and Training Administration, TAACCCT grant agreement # TC-22505-11-60-A25.The solution was created by the grantee and does not necessarily reflect the official position of the U.S. Department of Labor. The Department of Labor makes no guarantees, warranties, or assurances of any kind, exp ...
PROTEIN BINDING
PROTEIN BINDING

... but drugs with higher affinity will replace those drugs with lower affinity by competition Only free and unbound drugs exert therapeutic effect by interacting with ...
Pharmacology Review
Pharmacology Review

... Potency is the amount of a drug used to produce an effect. The more potent the drug is, the lower the dose needed to produce an effect. (Potency is greater when dose is smaller.) Efficacy is the maximum effect or response that can be produced by a drug no matter what the dose is. Administering more ...
drug names - Dentalelle Tutoring
drug names - Dentalelle Tutoring

... Therapeutically Equivalent – Equal therapeutic effects during a clinical trial ...
A CROSS-SECTIONAL, OBSERVATIONAL, PROSPECTIVE STUDY FOR EVALUATION OF
A CROSS-SECTIONAL, OBSERVATIONAL, PROSPECTIVE STUDY FOR EVALUATION OF

... contraindications and appropriate dosages to assure a safer use so that we can avoid ADRs [1]. Drugs play an important role in improving human health and promoting well being. However, to produce the desired effect they have to be safe, efficacious and have to be used rationally. In pregnancy, drug ...
< 1 ... 124 125 126 127 128 129 130 131 132 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report